ST ELIZABETH S MEDICAL CT INC has a total of 11 patent applications. Its first patent ever was published in 1999. It filed its patents most often in Australia, Canada and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ZENSUN SHANGHAI SCIENCE AND TECHNOLOGY LTD, NAT JEWISH MED & RES CENTER and SVANBORG CATHARINA.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | Canada | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Hong Kong | 1 | |
#5 | Japan | 1 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Environmental technology | |
#5 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Climate change adaptation technologies | |
#6 | Analysing materials | |
#7 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Walsh Kenneth | 5 |
#2 | Isner Jeffrey M | 4 |
#3 | Oh S Steven | 2 |
#4 | Chishti Athar H | 2 |
#5 | Liu David | 2 |
#6 | Goel Vikas | 2 |
#7 | Palasis Maria | 1 |
#8 | Li Xuerong | 1 |
Publication | Filing date | Title |
---|---|---|
AU2916902A | Glycogen synthase kinase function in endothelial cells | |
WO02070542A2 | Band 3 antigenic peptides, malaria polypeptides and uses thereof | |
AU4342700A | Angiogenic growth factors for treatment of peripheral neuropathy | |
AU6276399A | AKT compositions for enhancing survival of cells |